Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.508
Delayed Data
As of Sep 23
 +0.018 / +3.67%
Today’s Change
0.46
Today|||52-Week Range
2.83
-58.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2011
Quarter 4
2011
Quarter 1
2012
Quarter 2
2016
Revenue and IncomeNet Revenues1.2M1.2M1.3M2.1M
 
 
 
 
 
Cost of Goods Sold0.007.5M5.1M--
 
 
 
Depreciation And Amortization19.0K19.0K19.0K47.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.2M-6.3M-3.8M--
 
 
 
 
General Expenses5.3M1.7M1.7M7.1M
 
 
 
 
 
Research And Development3.8M----4.7M
 
 
 
Total Operating Expenses5.3M9.2M6.8M7.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.1M-8.0M-5.5M-5.0M
 
 
 
 
 
Extraordinary Credit0.000.000.008.0K
 
 
Extraordinary Charge0.00-1.6M0.00-1.9M
 
 
 
Other Expenses8.6M36.0K-1.4M-35.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.5M-9.6M-6.9M-6.9M
 
 
 
 
 
Net Income4.5M-9.6M-6.9M-6.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.7M9.7M10.2M29.9M
 
 
 
 
 
Shares To Calculate EPS Diluted10.0M9.7M10.2M29.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.45-$0.98-$0.67-$0.23
 
 
 
 
 
EPS Diluted$0.45-$0.98-$0.67-$0.23